AI Science Tracker

Zhejiang University of Technology

4 discoveries from 2023 to 2026

Discoveries

AI-guided natural-product-inspired molecules inhibit two multidrug-resistance transporters

Combining marine natural-product fragment mining, AI-based molecular generation and structure-guided selection, the authors designed optimized analogues Ib18 and It12 targeting the ABC transporters P-glycoprotein (ABCB1) and BCRP (ABCG2). Both analogues reversed transporter-mediated resistance in overexpressing cells and outperformed reference inhibitors. Target-engagement assays supported transporter inhibition without expression downregulation. In xenografts, Ib18 increased mitoxantrone antitumor activity and tumor accumulation without a detected increase in systemic toxicity.

Technology: AI-based molecular generation integrated with marine natural-product fragment mining and structure-guided prioritization

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Target-engagement assays supported transporter inhibition without expression downregulation.
  • Still unknown: The evidence is cellular and preclinical xenograft evidence, not patient efficacy or established clinical safety. The abstract reports no systemic toxicity increase in the studied xenograft setting, which should not be generalized. It does not give quantitative potency values or detailed comparator identities in the abstract.
  • AI role: AI-based generation contributed candidates to a natural-product-inspired library; structure-guided prioritization selected optimized analogues for synthesis and functional tests. The authors tested Ib18 and It12 in transporter-overexpressing cells and evaluated Ib18 with mitoxantrone in xenografts.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42720471/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Deep-learning-guided mining of NRPS scaffolds yields active naturally inspired antimicrobial peptides

The team mined 216,408 bacterial genomes, identifying 335,024 NRPS clusters and 328 dereplicated peptide scaffolds. Deep-learning scoring selected five synthesized peptides; P2 showed MIC50 values of 1–2 μM against Vibrio parahaemolyticus and V. alginolyticus. Deep-learning-guided sequence optimization produced P2.2, which showed increased antibacterial activity, membrane effects and reduced hemolysis in assays.

Technology: Deep-learning peptide activity scoring and sequence-optimization algorithms

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Deep-learning-guided sequence optimization produced P2.2, which showed increased antibacterial activity, membrane effects and reduced hemolysis in assays.
  • Still unknown: The study calls the peptides naturally inspired; it did not establish that the synthesized sequences are the native products of the mined clusters. P2's MIC50 of 1–2 μM did not mean 80% inhibition: its MIC80 exceeded 128 μM under the reported 24-hour conditions. P2.2's measured MIC80 values were 32 μM for V. parahaemolyticus and 64 μM for V. alginolyticus. These are in-vitro findings, not clinical efficacy.
  • AI role: AI-ranked peptide candidates inspired by nonribosomal peptide synthetase cluster scaffolds from bacterial genomes and guided amino-acid optimization of P2 into P2.2; the selected sequences were synthesized and tested in vitro.

Evidence sources: https://homepage.zjut.edu.cn/_upload/article/files/51/c3/6b78dffc40f7932148ad26cbf65b/e1d2421e-c600-4dac-82a5-bc29fa545929.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 12 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Machine learning screened metal oxides for acetylene semihydrogenation

A neural-network model was used to predict metal-oxide catalyst performance for acetylene semi-hydrogenation. The authors report experimental validation of predictions for CuO, ZnO and V2O5, and report 99.6% conversion with 90% ethylene selectivity for CuO under the abstract-described conditions. The entry is limited to the publisher abstract; detailed model validation, candidate selection and full assay context were not reviewed.

Technology: Neural-network prediction of metal-oxide catalyst performance

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The publisher abstract says CuO, ZnO and V2O5 predictions were experimentally validated; it reports 99.6% conversion and 90% ethylene selectivity for CuO at 50–100°C.
  • Still unknown: Detailed selection chronology, model split/performance, full test conditions and results for ZnO and V2O5 were not established from the reviewed abstract. The date is the publisher-displayed date, not a claim of first public appearance.
  • AI role: A neural-network model predicted catalyst performance and informed the metal-oxide candidates reported as experimentally validated.

Evidence sources: https://www.sciencedirect.com/science/article/pii/S0926860X24004149 · https://homepage.zjut.edu.cn/ljh_en/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary publisher abstract for identity, displayed date, model and reported experiment; official Zhejiang University of Technology faculty profile/publication list for named contributor affiliation. Full paper methods and supplement not reviewed..

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

PhotoCat guides experimental discovery of photocatalytic reactions

The PhotoCat Transformer was pretrained on general reaction data and fine-tuned on the authors’ photocatalysis database to predict products and reaction conditions. In the 2023 ChemRxiv version, the authors report using it to guide experimental validation of previously unreported photocatalytic reactions. The later 2026 journal version describes four novel validated reactions, whereas the preprint reports five; this entry makes no exact-count claim and treats the journal article as a revised version of the same study.

Technology: Transformer-based deep-learning reaction predictor pretrained on USPTO and fine-tuned on PhotoCatDB, with reaction-condition inputs

Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Preprint
  • Test type: direct test
  • Tested: The PhotoCat Transformer was pretrained on general reaction data and fine-tuned on a photocatalysis database to predict products and conditions. The 2023 ChemRxiv version reports wet-lab validation of five predicted reactions; the 2026 journal abstract reports four novel validated reactions.
  • Still unknown: The preprint and journal version differ in their reported count of validated novel reactions. This record states the shared model-guided experimental discovery claim and makes no exact-count claim.
  • AI role: A Transformer reaction predictor was pretrained on USPTO and fine-tuned on PhotoCatDB to rank photocatalytic reaction outcomes and conditions, guiding experimental validation.

Evidence sources: https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/65004fd999918fe537d200ab/original/photo-cat-an-artificial-intelligence-driven-synthesis-planning-platform-for-photocatalysis.pdf · https://pmc.ncbi.nlm.nih.gov/articles/PMC12913628/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary ChemRxiv v2 full-text PDF and version-history metadata; primary PMC full-text journal version and publication metadata. The preprint and journal versions report different counts (five versus four); the summary preserves this discrepancy..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.